PEAK6 Investments’s Axonics, Inc. Common Stock AXNX Stock Holding History

PEAK6 Investments’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,541	Closed	-$222K	–	6635
2022 Q1	$222K	Sell	3,541 -7,910	-69%	-$426K	﹤0.01%	3803
2021 Q4	$641K	Buy	+11,451	New	+$700K	﹤0.01%	2995
2021 Q3	–	Sell	-3,182	Closed	-$217K	–	5949
2021 Q2	$202K	Buy	+3,182	New	+$188K	﹤0.01%	4026
2021 Q1	–	Sell	-25,825	Closed	-$1.4M	–	5677
2020 Q4	$1.29M	Buy	25,825 +4,752	+23%	+$223K	﹤0.01%	2242
2020 Q3	$1.08M	Buy	21,073 +9,065	+75%	+$378K	﹤0.01%	2201
2020 Q2	$422K	Buy	+12,008	New	+$414K	﹤0.01%	2820

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PEAK6 Investments's AXNX Position: Q2 2022 in Review

PEAK6 Investments sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2022, closing a stake of 3,541 shares — an estimated $222K sold.

PEAK6 Investments first reported a position in AXNX in Q2 2020 and held it in 6 quarters. The position peaked at $1.29M in Q4 2020. 196 funds tracked by Wall St. Rank hold AXNX as of Q2 2022.

PEAK6 Investments reported no remaining Axonics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
PEAK6 Investments sold 3,541 Axonics, Inc. Common Stock shares in Q2 2022, an estimated $222K.
PEAK6 Investments first reported a position in Axonics, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
PEAK6 Investments's Axonics, Inc. Common Stock position peaked at $1.29M in Q4 2020.
196 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2022.

Based on PEAK6 Investments's 13F filing for Q2 2022, filed 12 Aug 2022.